Back

Identifying distinct clinical subgroups in heart failure with reduced ejection fraction

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Heart failure with reduced ejection fraction (HFrEF) 3 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Alicia Uijl

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Gender difference and clinical course of atrial fibrillation in patients with non-ischaemic cardiomyopathy
Doctor I. Chung (Singapore, SG)
Abstract Slides
Presentation thumbnail
The relationship between the right ventricular function, cardiac catheterization and CPET parameters in patients with advanced heart failure
Professor R. Acar (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
Doctor C. Paitazoglou (Luebeck, DE)
Abstract Slides
Presentation thumbnail
The first audit in real-world titration pattern of maximisation of four pillars of heart failure therapy to target doses in Irish nurse-led clinics.
Ms C. Murphy (Wexford, IE)
Abstract Slides
Presentation thumbnail
Impact of heart failure evidence-based-therapy in hypotensive patients
Doctor A. Fonseca (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with reduced ejection fraction (HFrEF) 3

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources